The chemistry question behind the label, answered the way the verification system actually handles it: the profile is documented, not assumed.
The short answer
A verified 7-OH tablet is made of 7-hydroxymitragynine as the labeled active — the printed milligram refers to that alkaloid — and the batch COA documents the full compound profile, including the related-alkaloid screens. The family map is in the alkaloid comparison: mitragynine is the leaf’s primary native compound, 7-OH is the concentrated native compound, and the semi-synthetic and analog compounds (MP, MGM-15, MGM-16) are scheduled and are not part of a legitimate 7-OH product.
Why the 2026 profile is the one to check
The reason this question matters more in 2026 than a year ago: the DEA’s August 26, 2026 action placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 on temporary Schedule I (the DEA update has the actions and dates), and the pending 7-OH threshold rule keeps the federal picture moving (the federal status guide tracks it). The practical expression of all of it is the lab panel: a current batch COA should show the 7-hydroxymitragynine content at the labeled amount and show the related-compound screens clean. The COA guide shows exactly which lines to look for, and the five-minute batch verification check is the habit that applies it to the pack in hand. The chemistry behind the distinction — what 7-OH is, where it comes from, and how it relates to mitragynine — is covered in what is 7-OH and the mitragynine vs 7-OH comparison.
Related reading
- Platinum 100mg — profile documented per batch
- Black Edition 50mg — profile documented per batch
- The full alkaloid family map
- The lines to check on a COA
- Back to the full FAQ hub — all 50 answers
21+ adult product. General information only — not legal or medical advice. Questions? Contact us (Mon–Fri, 9am–5pm PT, +1 (213) 357-1073, [email protected]).